Expression of sialylated MUC1 in prostate cancer: Relationship to clinical stage and prognosis

Abstract

These results suggest that sialylated MUC1 plays an important role in the progression of prostate cancer, and that its expression level in the primary lesion is a useful marker for the prognoses of patients undergoing endocrine therapy.